GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
62 hedge funds and large institutions have $14.6M invested in Genocea Biosciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
84% less capital invested
Capital invested by funds: $88.7M → $14.6M (-$74.2M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $242K
Holders
62
Holding in Top 10
1
Calls
$1K
Puts
$242K
Top Buyers
| 1 | +$296K | |
| 2 | +$180K | |
| 3 | +$158K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$134K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65K |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$4.93M | |
| 3 | -$2.51M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.14M |
| 5 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$748K |